X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3920) 3920
Publication (635) 635
Book Review (20) 20
Book Chapter (7) 7
Conference Proceeding (5) 5
Book / eBook (3) 3
Magazine Article (3) 3
Data Set (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2316) 2316
organophosphonates - pharmacology (1979) 1979
animals (1553) 1553
adenine - analogs & derivatives (1522) 1522
index medicus (1428) 1428
pharmacology & pharmacy (1230) 1230
male (987) 987
tenofovir (921) 921
female (897) 897
organophosphonates - chemistry (779) 779
antiviral agents - pharmacology (772) 772
adenine - pharmacology (766) 766
organophosphonates (734) 734
organophosphonates - therapeutic use (719) 719
adenine - therapeutic use (675) 675
adult (571) 571
cytosine - analogs & derivatives (545) 545
antiviral agents - therapeutic use (521) 521
mice (497) 497
rats (495) 495
organophosphonates - chemical synthesis (486) 486
organophosphonates - administration & dosage (458) 458
biochemistry & molecular biology (454) 454
middle aged (450) 450
virology (450) 450
chemistry, medicinal (449) 449
hiv infections - drug therapy (430) 430
structure-activity relationship (427) 427
microbiology (411) 411
antiviral agents (408) 408
infectious diseases (403) 403
organophosphorus compounds - pharmacology (380) 380
adenine - administration & dosage (375) 375
enzyme inhibitors - pharmacology (340) 340
cytosine - pharmacology (323) 323
cidofovir (312) 312
hepatitis b, chronic - drug therapy (310) 310
kinetics (303) 303
lamivudine (291) 291
cell line (286) 286
anti-hiv agents - pharmacology (283) 283
drug therapy, combination (281) 281
hiv-1 - drug effects (281) 281
dose-response relationship, drug (276) 276
molecular structure (276) 276
hiv (274) 274
mutation (272) 272
treatment outcome (269) 269
virus diseases (268) 268
hepatitis b virus - drug effects (265) 265
infection (264) 264
anti-hiv agents - therapeutic use (261) 261
in-vitro (261) 261
drug resistance, viral (250) 250
lamivudine - therapeutic use (239) 239
reverse transcriptase inhibitors - pharmacology (236) 236
analysis (235) 235
cells, cultured (234) 234
organophosphonates - pharmacokinetics (231) 231
time factors (231) 231
antiviral agents - administration & dosage (229) 229
virus replication - drug effects (229) 229
therapy (228) 228
adenine - pharmacokinetics (227) 227
lamivudine - pharmacology (224) 224
organophosphonates - adverse effects (221) 221
adenine - adverse effects (218) 218
chemistry, organic (217) 217
hepatitis b virus - genetics (214) 214
organophosphonates - metabolism (212) 212
emtricitabine (209) 209
guanine - analogs & derivatives (204) 204
pharmacokinetics (201) 201
cytosine - therapeutic use (200) 200
anti-hiv agents - administration & dosage (195) 195
resistance (194) 194
adefovir (192) 192
deoxycytidine - analogs & derivatives (192) 192
phosphonates (192) 192
article (191) 191
viruses (190) 190
reverse transcriptase inhibitors - therapeutic use (185) 185
derivatives (184) 184
hepatitis b (182) 182
models, molecular (181) 181
organophosphorus compounds - therapeutic use (178) 178
viral load (177) 177
in vitro techniques (173) 173
immunology (170) 170
health aspects (169) 169
hiv infections - virology (169) 169
replication (163) 163
analogs (161) 161
antiviral agents - chemistry (160) 160
aged (158) 158
research (157) 157
hepatitis b, chronic - virology (156) 156
adefovir dipivoxil (152) 152
microbial sensitivity tests (150) 150
antiviral activity (149) 149
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3708) 3708
Russian (69) 69
German (37) 37
Chinese (34) 34
French (27) 27
Spanish (21) 21
Japanese (17) 17
Turkish (4) 4
Polish (3) 3
Ukrainian (3) 3
Czech (2) 2
Italian (2) 2
Hebrew (1) 1
Hungarian (1) 1
Korean (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Mayo Clinic Proceedings, ISSN 0025-6196, 2011, Volume 86, Issue 10, pp. 1009 - 1026
Abstract Most viral diseases, with the exception of those caused by human immunodeficiency virus, are self-limited illnesses that do not require specific... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | HERPES-SIMPLEX-VIRUS | TENOFOVIR DISOPROXIL FUMARATE | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | POSITIVE CHRONIC HEPATITIS | CHRONIC HEPATITIS-B | ALPHA-2A PLUS RIBAVIRIN | CONGO HEMORRHAGIC-FEVER | ACUTE INTERSTITIAL NEPHRITIS | RECURRENT GENITAL HERPES | HIV-INFECTED PATIENTS | Acyclovir - therapeutic use | Foscarnet - pharmacology | Hepatitis C - drug therapy | HIV Infections - epidemiology | Humans | Ganciclovir - analogs & derivatives | Interferons - therapeutic use | Oligopeptides - therapeutic use | Hepatitis - drug therapy | Adenine - therapeutic use | Lamivudine - therapeutic use | Ganciclovir - therapeutic use | Proline - pharmacology | Protease Inhibitors - therapeutic use | Guanine - therapeutic use | Oseltamivir - pharmacology | Virus Replication - drug effects | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Comorbidity | Interferons - pharmacology | Pyrimidinones - therapeutic use | Acyclovir - pharmacology | Zanamivir - therapeutic use | Herpesviridae Infections - drug therapy | Thymidine - analogs & derivatives | Valine - therapeutic use | Oligopeptides - pharmacology | Ribavirin - pharmacology | Guanine - analogs & derivatives | Oseltamivir - therapeutic use | Guanine - pharmacology | Hepatitis C - epidemiology | Nucleosides - pharmacology | Ganciclovir - pharmacology | Pyrimidinones - pharmacology | Influenza, Human - drug therapy | Drug Therapy, Combination | Nucleosides - therapeutic use | Acyclovir - analogs & derivatives | Ribavirin - therapeutic use | Valine - analogs & derivatives | Zanamivir - pharmacology | Adenine - pharmacology | Proline - therapeutic use | Organophosphonates - pharmacology | Hepatitis B, Chronic - drug therapy | HIV Infections - drug therapy | Lamivudine - pharmacology | Foscarnet - therapeutic use | Valine - pharmacology | Amantadine - pharmacology | Antiviral agents | Diagnosis | Research | Drug therapy | HIV infection | Health aspects | Symposium on Antimicrobial Therapy
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2014, Volume 289, Issue 30, pp. 21082 - 21097
Journal Article
Journal Article
Journal Article
AIDS, ISSN 0269-9370, 07/2012, Volume 26, Issue 11, pp. 1371 - 1385
Background: The effect of specific antiretrovirals on inflammation is unclear. Methods: A5224s was a substudy of A5202, which randomized HIV-infected... 
endothelial activation markers | abacavir | C-reactive protein | TNF alpha | inflammation markers | interleukin-6 | INTIMA-MEDIA THICKNESS | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | BONE-MINERAL DENSITY | IMMUNOLOGY | HIV-INFECTED PATIENTS | TENOFOVIR-EMTRICITABINE | INDIVIDUAL ANTIRETROVIRAL DRUGS | VIROLOGY | CLINICAL-TRIALS | ACUTE MYOCARDIAL-INFARCTION | Anti-HIV Agents - pharmacology | Humans | Tumor Necrosis Factor-alpha - blood | Deoxycytidine - pharmacology | Male | Inflammation - blood | Tenofovir | Acquired Immunodeficiency Syndrome - immunology | C-Reactive Protein - metabolism | Interleukin-6 - blood | Atazanavir Sulfate | Adult | Female | Ritonavir - pharmacology | C-Reactive Protein - drug effects | Acquired Immunodeficiency Syndrome - blood | Emtricitabine | Dideoxynucleosides - pharmacology | HIV-1 - metabolism | Adenine - analogs & derivatives | Adenine - pharmacology | Inflammation - immunology | Biomarkers - blood | Acquired Immunodeficiency Syndrome - drug therapy | Organophosphonates - pharmacology | Tumor Necrosis Factor-alpha - drug effects | Benzoxazines - pharmacology | Lamivudine - pharmacology | Pyridines - pharmacology | Oligopeptides - pharmacology | Deoxycytidine - analogs & derivatives | Drug Combinations | Antiviral agents | nucleoside reverse transcriptase inhibitors | RNA | Ritonavir | tenofovir | Lamivudine | Inflammation | Efavirenz | CD4 antigen | Cell adhesion molecules | Interleukin 6 | Abacavir | Age | Tumor necrosis factor- alpha
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2013, Volume 57, Issue 5, pp. 2076 - 2086
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
TRANSIENT EXPRESSION | FC-RECEPTOR | HIV-1 ENVELOPE | CD4-BINDING SITE | RAPID PRODUCTION | IMMUNODEFICIENCY-VIRUS TYPE-1 | NONNEUTRALIZING ANTIBODIES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SHIV CHALLENGE | CELL | RATIONAL DESIGN | Antibodies, Monoclonal - biosynthesis | Antiviral Agents - immunology | Cyclohexanes - pharmacology | Humans | HIV Envelope Protein gp120 - antagonists & inhibitors | Neutralization Tests | Antiviral Agents - metabolism | Recombinant Proteins - biosynthesis | HIV Envelope Protein gp120 - metabolism | Tenofovir | Antibodies, Neutralizing - immunology | HIV-1 - growth & development | Tobamovirus - genetics | HIV Antibodies - immunology | Immunoglobulin G - biosynthesis | Immunoglobulin G - immunology | HIV Antibodies - biosynthesis | Immunoglobulin G - pharmacology | HIV Antibodies - pharmacology | Antibodies, Monoclonal - immunology | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | HIV-1 - drug effects | Antibodies, Monoclonal - pharmacology | Antibodies, Neutralizing - pharmacology | Plant Lectins - pharmacology | Adenine - pharmacology | Recombinant Proteins - pharmacology | Drug Synergism | Triazoles - pharmacology | Organophosphonates - pharmacology | Animals | Chromatography, Affinity | Recombinant Proteins - immunology | Antibodies, Neutralizing - biosynthesis | Tobacco - genetics | Genetic Vectors | Drug Combinations | Index Medicus | Antiviral Agents
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 08/2003, Volume 278, Issue 32, pp. 29509 - 29514
Journal Article
Drugs, ISSN 0012-6667, 1/2014, Volume 74, Issue 1, pp. 75 - 97
A new single-tablet, fixed-dose formulation consisting of elvitegravir, an HIV-1 integrase strand transfer inhibitor (INSTI); cobicistat, a pharmacokinetic... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | COMBINATION TABLET | PROTEASE INHIBITOR | TREATMENT-EXPERIENCED PATIENTS | CO-FORMULATED ELVITEGRAVIR | DOUBLE-BLIND | INITIAL TREATMENT | PHARMACOLOGY & PHARMACY | TOXICOLOGY | DRUG-RESISTANCE | INTEGRASE INHIBITOR | ANTIRETROVIRAL TREATMENT | MOLECULAR-BASIS | Anti-HIV Agents - pharmacology | Tablets | Humans | Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | Deoxycytidine - pharmacology | Quinolones - pharmacology | Thiazoles - therapeutic use | Carbamates - pharmacokinetics | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Deoxycytidine - pharmacokinetics | Deoxycytidine - therapeutic use | Adenine - adverse effects | Quinolones - adverse effects | Adenine - therapeutic use | Quinolones - pharmacokinetics | Quinolones - therapeutic use | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Carbamates - pharmacology | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Organophosphonates - adverse effects | Adenine - pharmacology | Adenine - pharmacokinetics | Organophosphonates - pharmacokinetics | Organophosphonates - pharmacology | Anti-HIV Agents - pharmacokinetics | Carbamates - adverse effects | HIV Infections - drug therapy | Thiazoles - pharmacology | Carbamates - therapeutic use | Drug Combinations | Emtricitabine | Care and treatment | Adults | Dosage and administration | Health aspects | HIV infection
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 04/2015, Volume 12, Issue 1, p. 70
Journal Article
BRITISH JOURNAL OF PHARMACOLOGY, ISSN 0007-1188, 07/2008, Volume 154, Issue 5, pp. 1143 - 1149
Background and purpose: Although participation of opioids in antinociception induced by cannabinoids has been documented, there is little information regarding... 
CB2 receptor | peripheral antinociception | MOLECULAR-BIOLOGY | ENDOGENOUS OPIOIDS | ANANDAMIDE | PHOSPHOLIPASE A | MECHANICALLY-EVOKED-RESPONSES | SPINAL NEURONS | bremazocine | morphine | CB2 RECEPTORS | NEUROPATHIC PAIN | CB1 receptor | ACID AMIDE HYDROLASE | SNC80 | PHARMACOLOGY & PHARMACY | RAT-BRAIN | Cannabinoid Receptor Modulators - metabolism | Hyperalgesia - chemically induced | Rats, Wistar | Analgesics, Opioid - pharmacology | Dinoprostone | Male | Pain - chemically induced | Receptors, Opioid, mu - agonists | Pain - metabolism | Dose-Response Relationship, Drug | Piperidines - pharmacology | Indoles - pharmacology | Benzamides - pharmacology | Benzomorphans - pharmacology | Disease Models, Animal | Pyrazoles - pharmacology | Amidohydrolases - metabolism | Hyperalgesia - metabolism | Morphine - pharmacology | Pain - prevention & control | Receptors, Opioid, mu - metabolism | Receptors, Opioid, kappa - agonists | Enzyme Inhibitors - pharmacology | Receptor, Cannabinoid, CB2 - drug effects | Hyperalgesia - prevention & control | Rats | Amidohydrolases - antagonists & inhibitors | Piperazines - pharmacology | Arachidonic Acids - pharmacology | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Organophosphonates - pharmacology | Animals | Receptor, Cannabinoid, CB1 - drug effects | Pain Measurement | Receptors, Opioid, delta - agonists | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e55013
Background: Oral and vaginal preparations of tenofovir as pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection have demonstrated... 
NUCLEOSIDE | LAMIVUDINE | CELLS | ACTIVATION | PREEXPOSURE | METABOLISM | DIPHOSPHATE | MULTIDISCIPLINARY SCIENCES | DISOPROXIL FUMARATE | DILUTION ASSESSMENT | IMMUNODEFICIENCY-VIRUS ACTIVITY | Anti-HIV Agents - pharmacology | HIV Infections - prevention & control | Phosphorylation | Tablets | Vagina - drug effects | Humans | Middle Aged | Phosphorous Acids - administration & dosage | Anti-HIV Agents - administration & dosage | Phosphorous Acids - adverse effects | Tenofovir | Young Adult | Adenine - adverse effects | Phosphorous Acids - pharmacokinetics | Adult | Female | Vaginal Creams, Foams, and Jellies | Vagina - cytology | Adenine - analogs & derivatives | Administration, Oral | Anti-HIV Agents - adverse effects | Rectum - metabolism | Organophosphonates - adverse effects | Adenine - pharmacology | Adenine - pharmacokinetics | Adenine - administration & dosage | Organophosphonates - pharmacokinetics | Cross-Over Studies | Organophosphonates - administration & dosage | Organophosphonates - pharmacology | Phosphorous Acids - pharmacology | Anti-HIV Agents - pharmacokinetics | Adolescent | Vagina - virology | Vagina - metabolism | Infection | Clinical trials | HIV (Viruses) | Health aspects | Laboratories | Prophylaxis | Viruses | Infections | Drug development | Mens health | Randomization | Acquired immune deficiency syndrome--AIDS | Compartments | Human immunodeficiency virus--HIV | Drug dosages | Public health | Dosing | Antiretroviral drugs | Effectiveness | Vagina | Pharmacology | Metabolism | Medicine | Studies | Womens health | Collaboration | Rectum | Pharmacokinetics | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article